EP3229828
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.12.2015EP published:
5.4.2023EP application number:
15808177.8
EPO information:
European Patent Register
Max expiry date:
9.12.2035
Title in English:
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATIONLanguage of the patent:
English
Timeline
Today
10.12.2015EP application
5.4.2023EP Publication
Owner
Name:
Sanofi-Aventis Deutschland GmbHAddress:
Brüningstraße 50, 65929 Frankfurt, DE
Inventor
Name:
SOUHAMI, ElisabethAddress:
75008 Paris, FR
Name:
SILVESTRE, LouiseAddress:
75008 Paris, FR
Priority
Number:
14197685Date:
12.12.2014Country:
EP
Number:
15193940Date:
10.11.2015Country:
EP
Classification
Categories:
A61K 38/26, A61K 38/28, A61P 3/10